Background Ocular hypertension and open-angle glaucoma are well-known side-effects of
treatment with topical ophthalmic glucocorticoids. There is uncertainty about the risk of these …

Objective.—To determine whether the use of inhaled and nasal glucocorticoids is
associated with an increased risk of ocular hypertension or open-angle glaucoma. Design …

Background It is largely unknown if corticosteroid-induced open-angle glaucoma (OAG) is
an entity that is limited to a few susceptible individuals or whether it contributes significantly …

Elevation of intraocular pressure is a well-documented side-effect of both topical and
systemic administration of corticosteroids. The onset is usually in a matter of weeks after …

OBJECTIVE: Until recently, inhaled corticosteroids were not considered to cause elevated
intraocular pressure (IOP), although topical and oral corticosteroids have been shown to do …

Topical glucocorticoids are a well-known risk factor of intraocular pressure (IOP) elevation in
one third of the general population and in up to 90% of glaucomatous patients. Whether this …

Corticosteroids (glucocorticoids), used frequently as potent anti-inflammatory agents,
increase the risk of glaucoma by raising the intraocular pressure (IOP) when administered …

Aims There is evidence that large doses of inhaled corticosteroids lead to an increased risk
of glaucoma, cataracts and other problems associated with oral corticosteroid use. However …

Glucocorticoids are taken by approximately 2% of the US adult population at any given time.
The powerful anti-inflammatory and immunosuppressive benefits of these drugs must …

Clin Pharmacol Ther 1999; 66: 338–45. asymptomatic until visual-field loss is advanced
enough to effect the quality of life of the patient. Risk factors for steroid-induced glaucoma …